Innate Pharma SA - IPHA

Sector: Healthcare · Industry: Biological Products, (No Diagnostic Substances)
Website: No information yet · Social: No information yet

Company profile

Powered by TradingView

Quarter snapshot

Latest / Compare
Q3 2026 · Q2 2026
Value (USD)
Total reported value ($000)
$349K
QoQ value delta ($000)
$0 (0.0%)
Implied price effect (QoQ)
+0.01%
Shares
Total shares
192,407
QoQ shares delta
-11 (-0.01%)
Total shares held by funds (by quarter)
Shares (left)

Fund holders include prior positions carried forward until a new 13F confirms a change. Reported holders have reported a position in this security for that quarter; this is not the total number of 13F filers.

Market chart (IPHA)

Powered by TradingView
Interactive chart by TradingView.

Top holders (Q3 2026)

Top 25 only Full list
Partial Q3 2026 data: 2 holders have filed so far. Prior holders are carried forward until their next 13F confirms a change.
Manager Value ($000) Shares % of 13F
Lion Point Capital, LP 149 81,151 0.71%
MORGAN STANLEY 80 43,524 0.0%
SmartHarvest Portfolios, LLC 43 23,750 0.01%
XTX Topco Ltd 27 15,130 0.0%
CITADEL ADVISORS LLC 22 12,441 0.0%
JANE STREET GROUP, LLC 18 10,310 0.0%
RHUMBLINE ADVISERS 8 4,719 0.0%
UBS Group AG 2 1,363 0.0%
Farther Finance Advisors, LLC 0 10 0.0%
GAMMA Investing LLC 0 9 0.0%